open access

Vol 20, No 3 (2016)
ORIGINAL PAPERS
Published online: 2016-09-29
Get Citation

Association between vitamin D levels and arterial hypertension in women at very high cardiovascular risk

Bartosz Krzowski, Anna E. Platek, Anna Rys, Karolina Semczuk, Marcin Kotkowski, Anna Szyderska, Pawel Legosz, Filip M. Szymanski, Krzysztof J. Filipiak
DOI: 10.5603/AH.2016.0015
·
Arterial Hypertension 2016;20(3):102-107.

open access

Vol 20, No 3 (2016)
ORIGINAL PAPERS
Published online: 2016-09-29

Abstract

Background Vitamin D is a compound of great importance in controlling the biological functions of the body in a variety of ways. Significance of vitamin D in the pathogenesis and treatment of various diseases has been described repeatedly. One of the most discussed issues in the literature is the importance of vitamin D deficiency in the pathogenesis of hypertension. This relationship is particularly important in patients burdened with elevated cardiovascular risk, which undoubtedly represent patients with diagnosed disease of the cardiovascular system. The aim of the study was to determine the association between the occurrence of vitamin D deficiency and the prevalence of hypertension in premenopausal women at very high cardiovascular risk.

Materials and methods The study included 49 women who had previously been diagnosed with cardiovascular disease. In all patients enrolled in the study serum concentrations of vitamin D were measured and the patients were classified to have vitamin D deficiency or normal vitamin D level, based on the existing criteria. The patients were also tested for the occurrence of hypertension. Medical records of all patients were reviewed for early diagnosis of hypertension, and blood pressure measurements were performed on admission to the hospital before the surgery by a qualified physician, in a manner consistent with current guidelines

Results The study population was aged 47.7 ± 13.4 years. The mean body mass index was 25.2 kg/m2. Vitamin D deficiency was diagnosed in 25 (51%) patients, and hypertension was diagnosed in 30 women (61.2%). In patients with vitamin D deficiency hypertension occurred in 18 (72%) women, while in the group without vitamin D deficiency hypertension was diagnosed in 50% of cases (12 women). The observed difference between the groups was statistically significant (p = 0.049). There was no difference in the incidence of other cardiovascular risk factors between the groups, including the prevalence of dyslipidaemia or nicotine addiction.

Conclusion Association of hypertension with the vitamin D deficiency has been repeatedly underlined in many scientific studies. In the present group of patients at very high cardiovascular risk, we confirmed the relationship of vitamin D deficiency with the occurrence of hypertension. Exact confirmation of this issue requires further, largescale research, but this study may suggest the importance of vitamin D supplementation in these patients.

Abstract

Background Vitamin D is a compound of great importance in controlling the biological functions of the body in a variety of ways. Significance of vitamin D in the pathogenesis and treatment of various diseases has been described repeatedly. One of the most discussed issues in the literature is the importance of vitamin D deficiency in the pathogenesis of hypertension. This relationship is particularly important in patients burdened with elevated cardiovascular risk, which undoubtedly represent patients with diagnosed disease of the cardiovascular system. The aim of the study was to determine the association between the occurrence of vitamin D deficiency and the prevalence of hypertension in premenopausal women at very high cardiovascular risk.

Materials and methods The study included 49 women who had previously been diagnosed with cardiovascular disease. In all patients enrolled in the study serum concentrations of vitamin D were measured and the patients were classified to have vitamin D deficiency or normal vitamin D level, based on the existing criteria. The patients were also tested for the occurrence of hypertension. Medical records of all patients were reviewed for early diagnosis of hypertension, and blood pressure measurements were performed on admission to the hospital before the surgery by a qualified physician, in a manner consistent with current guidelines

Results The study population was aged 47.7 ± 13.4 years. The mean body mass index was 25.2 kg/m2. Vitamin D deficiency was diagnosed in 25 (51%) patients, and hypertension was diagnosed in 30 women (61.2%). In patients with vitamin D deficiency hypertension occurred in 18 (72%) women, while in the group without vitamin D deficiency hypertension was diagnosed in 50% of cases (12 women). The observed difference between the groups was statistically significant (p = 0.049). There was no difference in the incidence of other cardiovascular risk factors between the groups, including the prevalence of dyslipidaemia or nicotine addiction.

Conclusion Association of hypertension with the vitamin D deficiency has been repeatedly underlined in many scientific studies. In the present group of patients at very high cardiovascular risk, we confirmed the relationship of vitamin D deficiency with the occurrence of hypertension. Exact confirmation of this issue requires further, largescale research, but this study may suggest the importance of vitamin D supplementation in these patients.

Full Text:

View HTML
Get Citation

Keywords

vitamin D, hypertension, premenopausal women

About this article
Title

Association between vitamin D levels and arterial hypertension in women at very high cardiovascular risk

Journal

Arterial Hypertension

Issue

Vol 20, No 3 (2016)

Pages

102-107

Published online

2016-09-29

DOI

10.5603/AH.2016.0015

Bibliographic record

Arterial Hypertension 2016;20(3):102-107.

Keywords

vitamin D
hypertension
premenopausal women

Authors

Bartosz Krzowski
Anna E. Platek
Anna Rys
Karolina Semczuk
Marcin Kotkowski
Anna Szyderska
Pawel Legosz
Filip M. Szymanski
Krzysztof J. Filipiak

References (27)
  1. Szymański FM, Bomba-Opoń DA, Łęgosz P, et al. Miejsce witaminy D w codziennej praktyce klinicznej — interdyscyplinarne stanowisko ekspertow. Forum Medycyny Rodzinnej. 2015; 9: 391–402.
  2. Rutkowski P, Wysocki PJ, Nowecki ZI, et al. Czerniaki skory — zasady postępowania diagnostyczno-terapeutycznego w 2013 roku. Przegl Dermatol. 2013; 100: 1–15.
  3. Alvarez JA, Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010; 2010: 385–389.
  4. Shin JS, Choi MY, Longtine MS, et al. Vitamin D effects on pregnancy and the placenta. Placenta. 2010; 31(12): 1027–1034.
  5. Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013; 3(8): e003423.
  6. Chobanian AV. Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy. N Engl J Med. 2009; 361(9): 878–887.
  7. Cifkova R, Fodor G, Wohlfahrt P. Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update. Curr Hypertens Rep. 2016; 18(8): 62.
  8. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997; 30(2 Pt 1): 150–156.
  9. Tokarz A, Kusnierz-Cabala B, Kuźniewski M, et al. Seasonal effect of vitamin D deficiency in patients with acute myocardial infarction. Kardiol Pol. 2016; 74(8): 786–792.
  10. Oz F, Cizgici AY, Topuz M, et al. Vitamin D insufficiency is associated with coronary artery tortuosity. Kardiol Pol. 2017; 75(2): 174–180.
  11. Cerit L, Duygu H, Gulsen K, et al. The relation between vitamin B12 and SYNTAX score. Kardiol Pol. 2017; 75(1): 65–70.
  12. Makarewicz-Wujec M, Kozłowska-Wojciechowska M, Sygnowska E, et al. Does heart failure determine the nutrition of patients? Kardiol Pol. 2014; 72(1): 56–63.
  13. Lind L, Lithell H, Skarfors E, et al. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988; 223(3): 211–217.
  14. Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet B and blood pressure. Lancet. 1998; 352(9129): 709–710.
  15. Chen S, Sun Y, Agrawal DK. Vitamin D deficiency and essential hypertension. J Am Soc Hypertens. 2015; 9(11): 885–901.
  16. Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J. 2010; 103(8): 729–737.
  17. Larsen T, Mose FH, Bech JN, et al. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012; 25(11): 1215–1222.
  18. Chen WR, Liu ZY, Shi Y, et al. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: a randomized placebo-controlled trial. Atherosclerosis. 2014; 235(1): 102–109.
  19. Mozaffari-Khosravi H, Loloei S, Mirjalili MR, et al. The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial. Blood Press Monit. 2015; 20(2): 83–91.
  20. Konijeti GG, Arora P, Boylan MR, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation. 2015; 131(3): 254–262.
  21. Hsia J, Heiss G, Ren H, et al. Women's Health Initiative Investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007; 115(7): 846–854.
  22. Spiro A, Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014; 39(4): 322–350.
  23. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008; 52(5): 828–832.
  24. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008; 88(2): 500S–506S.
  25. Li YC, Qiao G, Uskokovic M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2): 229–238.
  26. Li Y, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2): 229–238.
  27. Somjen D, Weisman Y, Kohen F, et al. 25-Hydroxyvitamin D3-1 -Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds. Circulation. 2005; 111(13): 1666–1671.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl